United States · FDA National Drug Code directory
Olmesartan Medoxomil and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-150_b993c27f-9ada-45be-bb55-245e11564d83
- Product NDC
- 46708-150
- Form
- TABLET
- Composition / generic term
- Olmesartan Medoxomil and Hydrochlorothiazide
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170424
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 40 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 80 TABLET in 1 CARTON (46708-150-08) · 46708-150-08
- 100 TABLET in 1 CARTON (46708-150-10) · 46708-150-10
- 30 TABLET in 1 BOTTLE (46708-150-30) · 46708-150-30
- 90 TABLET in 1 BOTTLE (46708-150-90) · 46708-150-90
- 1000 TABLET in 1 BOTTLE (46708-150-91) · 46708-150-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →